AUS
NZ
UK
CA
USA
IND
Highlights:
Australian equities tracked by asx 200 futures slipped in the mid-session on Friday, influenced by international trade developments and sector-wide declines. The broader S&P/ASX 200 index saw limited support outside of mining and utility stocks, with banking, tech, and healthcare sectors pulling back.
Miners and Utilities Provide Limited Support
Resource-heavy sectors remained relatively resilient. Bellevue Gold (ASX:BGL) lifted after offering its forward production outlook. The strength in commodities offered a buffer against broader weakness, although the gains were not enough to offset the losses across financials and technology names.
Downer EDI (ASX:DOW) announced a new defence contract, supporting its share price amid wider losses in industrials. Meanwhile, conglomerate Washington H Soul Pattinson (ASX:SOL) edged lower even after declaring an increase in its dividend payout.
Healthcare Rises on Strong ResMed Results
Healthcare firm ResMed (ASX:RMD) delivered solid financial results, which were well received by the market. The company highlighted its confidence in maintaining momentum despite increasing competition from weight management drugs impacting demand in the sleep apnoea segment. The stock outperformed the sector, bucking the broader market downtrend.
Novonix Cancels Graphite Spin-Out
Battery materials producer Novonix (ASX:NVX) and Lithium Energy (ASX:LEL) officially cancelled the IPO of Axon Graphite, pointing to unfavourable equity market conditions. The decision included ceasing its previously announced transaction related to the Mt Dromedary graphite asset.
Novonix indicated it would reassess the future of the Mt Dromedary project. Directors representing Novonix on Axon’s board have since resigned. Both stocks were little changed on the news.
Notable Movements Among Large Caps
Major financials experienced downward pressure. Commonwealth Bank (ASX:CBA), National Australia Bank (ASX:NAB), WiseTech Global (ASX:WTC), and Xero (ASX:XRO) all recorded intraday declines. The weakness followed renewed tariff announcements from the US, affecting sentiment toward globally exposed companies.
Meanwhile, gold mining stocks Evolution Mining (ASX:EVN) and Northern Star Resources (ASX:NST) trended lower following updated coverage across the sector.
Small Cap Highlights
Among smaller stocks, Dragon Mountain Gold (ASX:DMG) rose after confirming full repayment of a convertible loan ahead of schedule. The move, enabled by new funding from a major shareholder, provides balance sheet flexibility.
Aurora Energy Metals (ASX:1AE) reported that Eagle Energy Metals, which holds an option over its uranium asset in the US, is moving toward a Nasdaq listing via a SPAC merger. This development could lead to share issuance and potential royalties for Aurora, dependent on future milestones.
Locksley Resources (ASX:LKY) announced a successful capital raise to support exploration and processing initiatives at its Mojave project in the US. The capital injection will support work across critical mineral targets including rare earths and antimony.
What caused the ASX to decline on Friday?The market dipped due to global tariff tensions and weakness across banks, healthcare, and tech stocks.
Why did ResMed perform well despite a falling market?
ResMed reported strong earnings results, leading to gains in contrast to broader sector weakness.
What happened to Novonix’s graphite IPO plans?
Novonix and Lithium Energy ended the Axon Graphite IPO due to unfavourable market conditions and have started reviewing future strategies.
Frequently Asked Questions
- What led to the broad downturn in the ASX today?
The ASX decline followed global tariff headlines and a dip in risk appetite, weighing on banking, healthcare, and tech sectors. - Which companies cancelled their graphite spin-out plans?
Novonix (ASX:NVX) and Lithium Energy (ASX:LEL) cancelled the Axon Graphite IPO and related transactions due to market conditions. - Which small cap gained after debt clearance?
Dragon Mountain Gold (ASX:DMG) gained after announcing the repayment of a convertible loan with new funding support.
